Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccine
Qian Chen(Suzhou Research Institute), Qihui Wang(Shanxi Agricultural University), George F. Gao(Chinese Academy of Sciences), Hui Wang(Peking University), Yuxuan Han(Chinese Academy of Sciences), Anqi Zheng(Peking University), Renyi Ma(Chinese Academy of Sciences), Pei Du(Chinese Academy of Sciences), Lianpan Dai(Chinese Academy of Sciences), Xu Zhao(South China University of Technology), Rong Zhang(Huazhong Agricultural University), Xin Zhao(Chinese Academy of Sciences), Huiting Yang(Chinese Academy of Sciences), Qingrui Huang(Dalian University of Technology), Xiaoyu Rong(Wenzhou Medical University), Jinghua Yan(National Computer Network Emergency Response Technical Team/Coordination Center of Chinar), Xuehui Ma(Northeast Institute of Geography and Agroecology)
Cited by 13
Related Papers
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
|Trends in Microbiology|2016|3.1k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k